Viewing Study NCT05474768


Ignite Creation Date: 2025-12-24 @ 5:42 PM
Ignite Modification Date: 2025-12-24 @ 5:42 PM
Study NCT ID: NCT05474768
Status: UNKNOWN
Last Update Posted: 2022-07-26
First Post: 2022-07-22
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Expectations and Beliefs of Transgender People Regarding Hormonal Treatment
Sponsor: Central Hospital, Nancy, France
Organization:

Study Overview

Official Title: Expectations and Beliefs of Transgender People Regarding Hormonal Treatment
Status: UNKNOWN
Status Verified Date: 2022-07
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Hormonal treatment of gender dysphoria can have repercussions on metabolism, cardiovascular system and fertility and represents à potential oncological risk. According to the recommendations of the Endocrine society. Therefore, initial assessment and follow-up visits are necessary and must be carried out to avoid the apparition of potentially undesirable effects.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: